FDA
approval
· 2022-09-26
FDA Approved: JAVYGTOR — Supplemental Application (Dr. Reddys Laboratories Inc)
Summary
The FDA approved a supplemental application for JAVYGTOR (sapropterin dihydrochloride) submitted by Dr. Reddys Laboratories Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for JAVYGTOR (SAPROPTERIN DIHYDROCHLORIDE)